The tide is high..., page-16

Hi Andrew,

From the announcement dated 04/12/18...

"The ultimate read-out for this program will be conducted in primary cells (cells derived directly from a living organism rather than the immortalised laboratory cells used here) and will demonstrate the absolute numbers of cells that we are able to successfully achieve gene-editing in relative to alternative delivery approaches (eg. electroporation and lipid-based delivery systems). The primary cells used in this read-out will be the cell type of interest for the ex vivo commercial applications of the CRISPR/Cas9 technology and should therefore directly inform the commercialisation prospects for the program."

Worth another read.

https://hotcopper.com.au/threads/ann-successful-delivery-of-cripr-cas9-into-cells-ex-vivo.4563699/?post_id=36739143 

Tony